Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akebia Therapeutics, Inc. | 152,830 | reported | 10 Jun 2025 | tx 24+467,934−13,701 |
| SCYNEXIS INC | 70,000 | reported | 26 Jun 2025 | tx 33+391,687 |
| CONTRAFECT Corp | 42,000 | reported | 17 May 2022 | tx 6+108,200 |
| Vericel Corp | 11,000 | reported | 16 Oct 2024 | tx 60+247,950−127,100 |
| KERYX BIOPHARMACEUTICALS INC | 0 | reported | 12 Dec 2018 | tx 10+120,000−170,000 |
| CUBIST PHARMACEUTICALS INC | 0 | reported | 21 Jan 2015 | tx 154+890,944−917,455 |
| MOMENTA PHARMACEUTICALS INC | 0 | reported | 01 Oct 2020 | tx 26+156,242−156,242 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jun 2025 | GRANT_AWARD | SCYNEXIS INC | 23,000 | 0.00 USD | |
| 26 Jun 2025 | GRANT_AWARD | SCYNEXIS INC | 23,000 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 35,700 | 0.00 USD | |
| 10 Jun 2025 | GRANT_AWARD | Akebia Therapeutics, Inc. | 53,600 | 0.00 USD | deriv |
| 16 Oct 2024 | EXERCISE | Vericel Corp | 5,833 | 13.05 USD | |
| 16 Oct 2024 | SALE | Vericel Corp | 5,833 | 41.36 USD | |
| 16 Oct 2024 | EXERCISE | Vericel Corp | 5,833 | 0.00 USD | deriv |
| 02 Oct 2024 | EXERCISE | Vericel Corp | 5,833 | 13.05 USD | |
| 02 Oct 2024 | SALE | Vericel Corp | 5,833 | 40.35 USD | |
| 02 Oct 2024 | EXERCISE | Vericel Corp | 5,833 | 0.00 USD | deriv |
| 18 Sept 2024 | EXERCISE | Vericel Corp | 5,834 | 13.05 USD | |
| 18 Sept 2024 | SALE | Vericel Corp | 5,834 | 45.54 USD | |
| 18 Sept 2024 | EXERCISE | Vericel Corp | 5,834 | 0.00 USD | deriv |
| 04 Sept 2024 | EXERCISE | Vericel Corp | 5,000 | 3.74 USD | |
| 04 Sept 2024 | SALE | Vericel Corp | 5,000 | 48.58 USD | |
| 04 Sept 2024 | EXERCISE | Vericel Corp | 5,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | SCYNEXIS INC | 23,000 | 0.00 USD | |
| 20 Jun 2024 | GRANT_AWARD | SCYNEXIS INC | 23,000 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 30,000 | 0.00 USD | |
| 06 Jun 2024 | GRANT_AWARD | Akebia Therapeutics, Inc. | 45,000 | 0.00 USD | deriv |
| 01 May 2024 | EXERCISE | Vericel Corp | 3,200 | — | |
| 01 May 2024 | GRANT_AWARD | Vericel Corp | 3,200 | 0.00 USD | deriv |
| 01 May 2024 | EXERCISE | Vericel Corp | 3,200 | 0.00 USD | deriv |
| 01 May 2024 | GRANT_AWARD | Vericel Corp | 8,000 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | SCYNEXIS INC | 10,000 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 21 Dec 2020.